Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Heller

Showing results (71-80 of 157) with videos related to

Pageof 16
Sort By:
Diabetes, Obesity & Metabolism|February 5, 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targetsVittorino Smaniotto, Simon Heller, David O'Neal, et al.
BMJ Open|September 7, 2020
Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health recordsRathi Ravindrarajah, David Reeves, Elizabeth Howarth, et al.
BMJ (Clinical Research Ed.)|April 28, 2012
Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary careKamlesh Khunti, Laura J Gray, Timothy Skinner, et al.
Plos Medicine|February 27, 2023
Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysisRathi Ravindrarajah, Matt Sutton, David Reeves, et al.
Diabetes & Vascular Disease Research|October 21, 2020
Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarctionColin C Everett, Catherine Reynolds, Catherine Fernandez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Pediatric Diabetes|January 11, 2007
The development of an innovative education curriculum for 11-16 yr old children with type 1 diabetes mellitus (T1DM)Julie Knowles, Helen Waller, Christine Eiser, et al.
Diabetes, Obesity & Metabolism|January 23, 2026
CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetesThomas Martens, Tadej Battelino, Simon Heller, et al.
Diabetes Care|October 6, 2011
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trialMark Woodward, Anushka Patel, Sophia Zoungas, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
Pageof 16

Showing results (71-80 of 157) with videos related to

Sort By:
Pageof 16
Diabetes, Obesity & Metabolism|February 5, 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targetsVittorino Smaniotto, Simon Heller, David O'Neal, et al.
BMJ Open|September 7, 2020
Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health recordsRathi Ravindrarajah, David Reeves, Elizabeth Howarth, et al.
BMJ (Clinical Research Ed.)|April 28, 2012
Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary careKamlesh Khunti, Laura J Gray, Timothy Skinner, et al.
Plos Medicine|February 27, 2023
Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysisRathi Ravindrarajah, Matt Sutton, David Reeves, et al.
Diabetes & Vascular Disease Research|October 21, 2020
Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarctionColin C Everett, Catherine Reynolds, Catherine Fernandez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Pediatric Diabetes|January 11, 2007
The development of an innovative education curriculum for 11-16 yr old children with type 1 diabetes mellitus (T1DM)Julie Knowles, Helen Waller, Christine Eiser, et al.
Diabetes, Obesity & Metabolism|January 23, 2026
CGM-derived efficacy and overall safety of once-weekly insulin efsitora alfa (efsitora) relative to day of administration in adults with type 2 diabetesThomas Martens, Tadej Battelino, Simon Heller, et al.
Diabetes Care|October 6, 2011
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trialMark Woodward, Anushka Patel, Sophia Zoungas, et al.
Diabetologia|September 18, 2014
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesSophia Zoungas, Mark Woodward, Qiang Li, et al.
Pageof 16